🌐 These Were The Winners And Losers In A Boring Year For Startup IPOs In 2024, the tech startup IPO landscape has been relatively dull, with few U.S. tech unicorns going public and biotech offerings falling short of previous highs. Aftermarket performance has been mixed, with some companies seeing significant gains while others remain flat or decline. Top Tech Performers: - Reddit: Shares up 332% since its March IPO, with a market cap of around $26 billion. - Astera Labs: Shares increased by 214% since debuting in March, valued at around $18 billion. - Other notable performers include Life360, Rubrik, and Serve Robotics. Tech Underperformers: - Webtoon Entertainment: Shares down about 33% since its June IPO. - Gauzy: Shares lost roughly 50% since debuting in June. - Ibotta: Down 17% from its offering price and 34% from its all-time high. Top Biotech Performers: - CG Oncology: Shares up 90% since its January IPO due to positive clinical trial results. - Ceribell: Shares increased by 70% since its October IPO. - Other successful biotech IPOs include ArriVent BioPharma and Septerna. Biotech Underperformers: - Metagenomi: Shares down over 80% since its February IPO. - FibroBiologics: Shares lost more than two-thirds of their value since its January direct listing. - Fractyl Health: Shares dropped more than 80% since debuting in February. Overall, while 56% of the 168 companies that went public in 2024 are trading above their offer price with an aggregate total return of around 8%, this performance lags behind the Nasdaq Composite Index, which has risen approximately 35% this year. 💬 Source 📌 Powered by V3V Ventures